373 related articles for article (PubMed ID: 31238901)
21. Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?
Zarić B; Kuruc V; Milovančev A; Markovic M; Šarčev T; Čanak V; Pavlović S
Lung; 2008; 186(4):233-240. PubMed ID: 18357489
[TBL] [Abstract][Full Text] [Related]
22. [Interleukin-20 and interleukin-22 in pleural effusion].
Cao TZ; Du RH; Lian Z; Jin W; Qiu M
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Aug; 39(8):608-11. PubMed ID: 27523894
[TBL] [Abstract][Full Text] [Related]
23. Association between elevated pleural interleukin-33 levels and tuberculous pleurisy.
Lee KS; Kim HR; Kwak S; Choi KH; Cho JH; Lee YJ; Lee MK; Lee JH; Park SD; Park DS
Ann Lab Med; 2013 Jan; 33(1):45-51. PubMed ID: 23301222
[TBL] [Abstract][Full Text] [Related]
24. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Yildiz PB; Yazar EE; Gorgun D; Secik F; Cakir G
Asian Pac J Cancer Prev; 2011; 12(2):419-23. PubMed ID: 21545206
[TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminase activity level as a tool for diagnosing tuberculous pleural effusion.
Khow-Ean N; Booraphun S; Aekphachaisawat N; Sawanyawisuth K
Southeast Asian J Trop Med Public Health; 2013 Jul; 44(4):655-9. PubMed ID: 24050100
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.
Zhao T; Zhang J; Zhang X; Wang C
BMC Pulm Med; 2024 May; 24(1):241. PubMed ID: 38750432
[TBL] [Abstract][Full Text] [Related]
27. Are soluble IL-2 receptor and IL-12p40 levels useful markers for diagnosis of tuberculous pleurisy?
Tural Önür S; Sökücü SN; Dalar L; Seyhan EC; Akbaş A; Altin S
Infect Dis (Lond); 2015 Mar; 47(3):150-5. PubMed ID: 25549699
[TBL] [Abstract][Full Text] [Related]
28. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
29. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
30. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of CD97 and CD55 levels in the differential diagnosis of tuberculous and malignant pleural effusions.
Wang C; Jie J; Li D; Liu Y; Gao J; Song L
Medicine (Baltimore); 2021 Jul; 100(30):e26771. PubMed ID: 34397724
[TBL] [Abstract][Full Text] [Related]
32. Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
Shi J; Li P; Zhou L; Qi S; Wang B; Li D; Duan L; Chen WX; Xia J; Zou L; Yang S
Biomark Med; 2019 Feb; 13(2):123-133. PubMed ID: 30791695
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis.
Liu Q; Yu YX; Wang XJ; Wang Z; Wang Z
Respiration; 2018; 95(6):469-477. PubMed ID: 29539604
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion.
Du J; Shao MM; Yi FS; Huang ZY; Qiao X; Chen QY; Shi HZ; Zhai K
Microbiol Spectr; 2022 Aug; 10(4):e0255321. PubMed ID: 35880892
[TBL] [Abstract][Full Text] [Related]
37. T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.
Roofchayee ND; Adcock IM; Marjani M; Dezfuli NK; Varahram M; Garssen J; Mortaz E
Front Immunol; 2021; 12():780453. PubMed ID: 34925358
[TBL] [Abstract][Full Text] [Related]
38. Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.
Jiang CG; Wang W; Zhou Q; Wu XZ; Wang XJ; Wang Z; Zhai K; Shi HZ
BMC Pulm Med; 2020 Jun; 20(1):178. PubMed ID: 32571326
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion.
Javath Hussain S; Selvaraj J; Mohanty Mohapatra M; Rajendiran S
Curr Probl Cancer; 2019 Aug; 43(4):354-362. PubMed ID: 30471784
[TBL] [Abstract][Full Text] [Related]
40. [Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].
Krenke R; Safianowska A; Paplińska M; Korczyński P; Dmowska-Sobstyl B; Bogacka-Zatorska E; Jaworski A; Chazan R
Pneumonol Alergol Pol; 2008; 76(4):237-45. PubMed ID: 18785128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
